Recombinant tetravalent human papillomavirus (16/18/52/58) virus-like particle vaccine (Shanghai institute of biological products)

重组四价人乳头瘤病毒(16/18/52/58型)病毒样颗粒疫苗（上海生物制品研究所有限责任公司）

Report date: 2026/04/14 20:00:15

Base Information

Drug NameRecombinant tetravalent human papillomavirus (16/18/52/58) virus-like particle vaccine (Shanghai institute of biological products)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Multivalent vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical NeoplasmsCervical Intraepithelial NeoplasiaAdenocarcinoma in Situ

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesShanghai Institute of Biological Products Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai Institute of Biological Products Co Ltd

Active IndicationsN/A

Inactive IndicationsUterine Cervical NeoplasmsCervical Intraepithelial NeoplasiaAdenocarcinoma in Situ

Other Information

ATC CodeN/A